GLP-1 receptor agonistGLP-1 Agonists

Ecnoglutide

A long-acting GLP-1 receptor agonist by Sciwind Biosciences. Designed for once-monthly subcutaneous injection with extended half-life. In Phase 2/3 clinical trials for obesity and type 2 diabetes.

weight-lossGLP-1long-actingmonthly-dosing
3D Structure
3D Structure
FormulaC194H304N48O61
PubChem CID162625103
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
Intensity21432684322537664307m/z4285.2
ESI-MS (computed)
Batch Info
Latest Batch
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity data
Lab Reports
0 reports on file
Summary

A long-acting GLP-1 receptor agonist by Sciwind Biosciences. Designed for once-monthly subcutaneous injection with extended half-life. In Phase 2/3 clinical trials for obesity and type 2 diabetes.